| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |